Validation and initial clinical use of automatic peak skin dose localization with fluoroscopic and interventional procedures

Yasaman Khodadadegan, Muhong Zhang, William Pavlicek, Robert G. Paden, Brian Chong, Eric A. Huettl, Beth A. Schueler, Kenneth A. Fetterly, Steve G. Langer, Teresa Wu

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Purpose: To assess the accuracy and initial clinical use of a software tool that automatically maps and records values of skin dose, including peak skin dose (PSD), administered to patients undergoing fluoroscopically guided interventional procedures. Materials and Methods: In this retrospective study, the institutional review board determined that this HIPAA-compliant study met the criteria as a quality assurance investigation. Informed consent was waived. After the initial validation and accuracy tests, distributed skin dose and PSD estimates were obtained for fluoroscopically guided interventional procedures performed in the radiology, cardiology, and gastroenterology practice areas between January and October 2011. A total of 605 procedures were performed in 520 patients (64% men; age range, 20-95 years). The accuracy of a skin dose tool to estimate patient dose distribution was verified with phantom studies by using an external dosimeter and direct exposure film. PSD distribution, PSD according to procedure type, and PSD for individual physician operators were assessed. Results: Calculated PSD values agreed within 69% of that measured by using film dosimetry under the condition of matched-phantom geometry. The area receiving the highest dose (greater than 95% of peak) agreed within ±17%. Of 605 patient procedures, 15 demonstrated PSD greater than 2 Gy, with a maximum PSD of 5.6 Gy. Conclusion: Knowledge of the patient skin dose can help direct treatment of patients who were administered relatively high skin dose and may be used to plan future procedures.

Original languageEnglish (US)
Pages (from-to)246-255
Number of pages10
JournalRadiology
Volume266
Issue number1
DOIs
StatePublished - Jan 2013

Fingerprint

Skin
Film Dosimetry
Health Insurance Portability and Accountability Act
Research Ethics Committees
Gastroenterology
Skin Tests
Cardiology
Informed Consent
Radiology
Software
Retrospective Studies
Physicians

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Cite this

Validation and initial clinical use of automatic peak skin dose localization with fluoroscopic and interventional procedures. / Khodadadegan, Yasaman; Zhang, Muhong; Pavlicek, William; Paden, Robert G.; Chong, Brian; Huettl, Eric A.; Schueler, Beth A.; Fetterly, Kenneth A.; Langer, Steve G.; Wu, Teresa.

In: Radiology, Vol. 266, No. 1, 01.2013, p. 246-255.

Research output: Contribution to journalArticle

Khodadadegan, Y, Zhang, M, Pavlicek, W, Paden, RG, Chong, B, Huettl, EA, Schueler, BA, Fetterly, KA, Langer, SG & Wu, T 2013, 'Validation and initial clinical use of automatic peak skin dose localization with fluoroscopic and interventional procedures', Radiology, vol. 266, no. 1, pp. 246-255. https://doi.org/10.1148/radiol.12112295
Khodadadegan, Yasaman ; Zhang, Muhong ; Pavlicek, William ; Paden, Robert G. ; Chong, Brian ; Huettl, Eric A. ; Schueler, Beth A. ; Fetterly, Kenneth A. ; Langer, Steve G. ; Wu, Teresa. / Validation and initial clinical use of automatic peak skin dose localization with fluoroscopic and interventional procedures. In: Radiology. 2013 ; Vol. 266, No. 1. pp. 246-255.
@article{d784955be2504df28dcb5fa0a68a9ff5,
title = "Validation and initial clinical use of automatic peak skin dose localization with fluoroscopic and interventional procedures",
abstract = "Purpose: To assess the accuracy and initial clinical use of a software tool that automatically maps and records values of skin dose, including peak skin dose (PSD), administered to patients undergoing fluoroscopically guided interventional procedures. Materials and Methods: In this retrospective study, the institutional review board determined that this HIPAA-compliant study met the criteria as a quality assurance investigation. Informed consent was waived. After the initial validation and accuracy tests, distributed skin dose and PSD estimates were obtained for fluoroscopically guided interventional procedures performed in the radiology, cardiology, and gastroenterology practice areas between January and October 2011. A total of 605 procedures were performed in 520 patients (64{\%} men; age range, 20-95 years). The accuracy of a skin dose tool to estimate patient dose distribution was verified with phantom studies by using an external dosimeter and direct exposure film. PSD distribution, PSD according to procedure type, and PSD for individual physician operators were assessed. Results: Calculated PSD values agreed within 69{\%} of that measured by using film dosimetry under the condition of matched-phantom geometry. The area receiving the highest dose (greater than 95{\%} of peak) agreed within ±17{\%}. Of 605 patient procedures, 15 demonstrated PSD greater than 2 Gy, with a maximum PSD of 5.6 Gy. Conclusion: Knowledge of the patient skin dose can help direct treatment of patients who were administered relatively high skin dose and may be used to plan future procedures.",
author = "Yasaman Khodadadegan and Muhong Zhang and William Pavlicek and Paden, {Robert G.} and Brian Chong and Huettl, {Eric A.} and Schueler, {Beth A.} and Fetterly, {Kenneth A.} and Langer, {Steve G.} and Teresa Wu",
year = "2013",
month = "1",
doi = "10.1148/radiol.12112295",
language = "English (US)",
volume = "266",
pages = "246--255",
journal = "Radiology",
issn = "0033-8419",
publisher = "Radiological Society of North America Inc.",
number = "1",

}

TY - JOUR

T1 - Validation and initial clinical use of automatic peak skin dose localization with fluoroscopic and interventional procedures

AU - Khodadadegan, Yasaman

AU - Zhang, Muhong

AU - Pavlicek, William

AU - Paden, Robert G.

AU - Chong, Brian

AU - Huettl, Eric A.

AU - Schueler, Beth A.

AU - Fetterly, Kenneth A.

AU - Langer, Steve G.

AU - Wu, Teresa

PY - 2013/1

Y1 - 2013/1

N2 - Purpose: To assess the accuracy and initial clinical use of a software tool that automatically maps and records values of skin dose, including peak skin dose (PSD), administered to patients undergoing fluoroscopically guided interventional procedures. Materials and Methods: In this retrospective study, the institutional review board determined that this HIPAA-compliant study met the criteria as a quality assurance investigation. Informed consent was waived. After the initial validation and accuracy tests, distributed skin dose and PSD estimates were obtained for fluoroscopically guided interventional procedures performed in the radiology, cardiology, and gastroenterology practice areas between January and October 2011. A total of 605 procedures were performed in 520 patients (64% men; age range, 20-95 years). The accuracy of a skin dose tool to estimate patient dose distribution was verified with phantom studies by using an external dosimeter and direct exposure film. PSD distribution, PSD according to procedure type, and PSD for individual physician operators were assessed. Results: Calculated PSD values agreed within 69% of that measured by using film dosimetry under the condition of matched-phantom geometry. The area receiving the highest dose (greater than 95% of peak) agreed within ±17%. Of 605 patient procedures, 15 demonstrated PSD greater than 2 Gy, with a maximum PSD of 5.6 Gy. Conclusion: Knowledge of the patient skin dose can help direct treatment of patients who were administered relatively high skin dose and may be used to plan future procedures.

AB - Purpose: To assess the accuracy and initial clinical use of a software tool that automatically maps and records values of skin dose, including peak skin dose (PSD), administered to patients undergoing fluoroscopically guided interventional procedures. Materials and Methods: In this retrospective study, the institutional review board determined that this HIPAA-compliant study met the criteria as a quality assurance investigation. Informed consent was waived. After the initial validation and accuracy tests, distributed skin dose and PSD estimates were obtained for fluoroscopically guided interventional procedures performed in the radiology, cardiology, and gastroenterology practice areas between January and October 2011. A total of 605 procedures were performed in 520 patients (64% men; age range, 20-95 years). The accuracy of a skin dose tool to estimate patient dose distribution was verified with phantom studies by using an external dosimeter and direct exposure film. PSD distribution, PSD according to procedure type, and PSD for individual physician operators were assessed. Results: Calculated PSD values agreed within 69% of that measured by using film dosimetry under the condition of matched-phantom geometry. The area receiving the highest dose (greater than 95% of peak) agreed within ±17%. Of 605 patient procedures, 15 demonstrated PSD greater than 2 Gy, with a maximum PSD of 5.6 Gy. Conclusion: Knowledge of the patient skin dose can help direct treatment of patients who were administered relatively high skin dose and may be used to plan future procedures.

UR - http://www.scopus.com/inward/record.url?scp=84871677129&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84871677129&partnerID=8YFLogxK

U2 - 10.1148/radiol.12112295

DO - 10.1148/radiol.12112295

M3 - Article

C2 - 23143024

AN - SCOPUS:84871677129

VL - 266

SP - 246

EP - 255

JO - Radiology

JF - Radiology

SN - 0033-8419

IS - 1

ER -